Endoscopy 2021; 53(S 01): S246-S247
DOI: 10.1055/s-0041-1724944
Abstracts | ESGE Days
ESGE Days 2021 Digital poster exhibition

Safety And Efficacy Of Endoscopic Ultrasound As A Diagnostic And Therapeutic Tool In Pediatric Patients: A Multi-Center Study

E Ghoneem
1   Faculty of Medicine, Mansoura University, Gastroenterology and Hepatology, Mansoura, Egypt
2   Egyptian Liver Research Institute and Hospital (ELRIAH), Gastroenterology and Hepatology, Mansoura, Egypt
,
H Okasha
3   Kasr al-Aini School of Medicine, Cairo University, Internal Medicine, Division of Hepatology and Gastroenterology, Cairo, Egypt
,
G Shiha
1   Faculty of Medicine, Mansoura University, Gastroenterology and Hepatology, Mansoura, Egypt
2   Egyptian Liver Research Institute and Hospital (ELRIAH), Gastroenterology and Hepatology, Mansoura, Egypt
,
R Soliman
4   Faculty of Medicine, Port Said University, Tropical Medicine Department, Port Said, Egypt
2   Egyptian Liver Research Institute and Hospital (ELRIAH), Gastroenterology and Hepatology, Mansoura, Egypt
,
M Gouda
5   Theodor Bilharz Research Institute, Hepatology and Gastroenterology, Cairo, Egypt
,
K Ragab
5   Theodor Bilharz Research Institute, Hepatology and Gastroenterology, Cairo, Egypt
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
 

Aims Assess the feasibility, safety and clinical impact of endoscopic ultrasound in pediatric patients.

Methods Between May 2017 to June 2020, at endoscopy unit of four Egyptian tertiary center, we included all pediatric patients (< 18 years) referred to EUS assessment who are clinically fit for the procedure. Significant impact was defined as a new diagnosis or treatment attributed to the EUS examination.

Results Twenty-nine pediatric patients (19 males and 10 females) with a median age of nine years (2.5: 15 years) who underwent EUS procedures for diagnostic (n = 24 cases; 13 child only for assessment and 11 child for tissue acquisition) and therapeutic (n = 5 cases) indications were included. Thirteen cases diagnosed by EUS without tissue acquisition (n = 7 chronic pancreatitis, n = 2 normal pancreas, n = 1 resolving pseudocyst, n = 1 rectal abscess with fistula, n = 2 duplication cysts), while eleven patients underwent EUS- guided tissue acquisition (n = 5 FNA and n = 6 FNB) with a definitive histopathological diagnosis in ten patients, while one case of inconclusive finding. Five patients underwent Cystogastrostomy for symptomatic pancreatic pseudocyst with technical and clinical success achieved in all patients. EUS could diagnose the disease in 21 of 24 patients (ten cases were histopathologically proven and 11 cases had the typical EUS criteria of a disease), while those cases unable to be successfully diagnosed included two with normal pancreases and one with inconclusive biopsy findings. There was no procedure related major complication, while minor related complication in two cases (pain in one case of FNB, mild and for 6 h; fever and vomiting in one of cystogastrostomy cases, last for 2 days).

Conclusions Standard EUS equipment and accessories can be used safely and effectively in pediatric patients for diagnosis of GI related diseases, especially pancreatico-biliary, and EUS guided Cystogastrostomy.

Citation Ghoneem E, Okasha H, Shiha G et al. eP455 SAFETY AND EFFICACY OF ENDOSCOPIC ULTRASOUND AS A DIAGNOSTIC AND THERAPEUTIC TOOL IN PEDIATRIC PATIENTS: A MULTI-CENTER STUDY. Endoscopy 2021; 53: S246.



Publikationsverlauf

Artikel online veröffentlicht:
19. März 2021

© 2021. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany